194 related articles for article (PubMed ID: 21693628)
1. Biomarkers related to one-carbon metabolism as potential risk factors for distal colorectal adenomas.
de Vogel S; Schneede J; Ueland PM; Vollset SE; Meyer K; Fredriksen A; Midttun Ø; Bjørge T; Kampman E; Bretthauer M; Hoff G
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1726-35. PubMed ID: 21693628
[TBL] [Abstract][Full Text] [Related]
2. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.
Wei EK; Giovannucci E; Selhub J; Fuchs CS; Hankinson SE; Ma J
J Natl Cancer Inst; 2005 May; 97(9):684-92. PubMed ID: 15870439
[TBL] [Abstract][Full Text] [Related]
3. Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study.
van den Donk M; Buijsse B; van den Berg SW; Ocké MC; Harryvan JL; Nagengast FM; Kok FJ; Kampman E
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1562-6. PubMed ID: 15941973
[TBL] [Abstract][Full Text] [Related]
4. Vitamins B2, B6, and B12 and risk of new colorectal adenomas in a randomized trial of aspirin use and folic acid supplementation.
Figueiredo JC; Levine AJ; Grau MV; Midttun O; Ueland PM; Ahnen DJ; Barry EL; Tsang S; Munroe D; Ali I; Haile RW; Sandler RS; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2136-45. PubMed ID: 18708408
[TBL] [Abstract][Full Text] [Related]
5. Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk.
Eussen SJ; Vollset SE; Hustad S; Midttun Ø; Meyer K; Fredriksen A; Ueland PM; Jenab M; Slimani N; Boffetta P; Overvad K; Thorlacius-Ussing O; Tjønneland A; Olsen A; Clavel-Chapelon F; Boutron-Ruault MC; Morois S; Weikert C; Pischon T; Linseisen J; Kaaks R; Trichopoulou A; Zilis D; Katsoulis M; Palli D; Pala V; Vineis P; Tumino R; Panico S; Peeters PH; Bueno-de-Mesquita HB; van Duijnhoven FJ; Skeie G; Muñoz X; Martínez C; Dorronsoro M; Ardanaz E; Navarro C; Rodríguez L; VanGuelpen B; Palmqvist R; Manjer J; Ericson U; Bingham S; Khaw KT; Norat T; Riboli E
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2549-61. PubMed ID: 20813848
[TBL] [Abstract][Full Text] [Related]
6. Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway.
Martínez ME; Thompson P; Jacobs ET; Giovannucci E; Jiang R; Klimecki W; Alberts DS
Gastroenterology; 2006 Dec; 131(6):1706-16. PubMed ID: 17087956
[TBL] [Abstract][Full Text] [Related]
7. Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake.
Han SS; Sue LY; Berndt SI; Selhub J; Burdette LA; Rosenberg PS; Ziegler RG
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):417-27. PubMed ID: 22253295
[TBL] [Abstract][Full Text] [Related]
8. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction?
Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):659-68. PubMed ID: 10744125
[TBL] [Abstract][Full Text] [Related]
9. Components of One-carbon Metabolism Other than Folate and Colorectal Cancer Risk.
Myte R; Gylling B; Schneede J; Ueland PM; Häggström J; Hultdin J; Hallmans G; Johansson I; Palmqvist R; Van Guelpen B
Epidemiology; 2016 Nov; 27(6):787-96. PubMed ID: 27367522
[TBL] [Abstract][Full Text] [Related]
10. Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan.
Otani T; Iwasaki M; Hanaoka T; Kobayashi M; Ishihara J; Natsukawa S; Shaura K; Koizumi Y; Kasuga Y; Yoshimura K; Yoshida T; Tsugane S
Nutr Cancer; 2005; 53(1):42-50. PubMed ID: 16351505
[TBL] [Abstract][Full Text] [Related]
11. Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European prospective investigation into cancer and nutrition.
Eussen SJ; Vollset SE; Hustad S; Midttun Ø; Meyer K; Fredriksen A; Ueland PM; Jenab M; Slimani N; Ferrari P; Agudo A; Sala N; Capellá G; Del Giudice G; Palli D; Boeing H; Weikert C; Bueno-de-Mesquita HB; Büchner FL; Carneiro F; Berrino F; Vineis P; Tumino R; Panico S; Berglund G; Manjer J; Stenling R; Hallmans G; Martínez C; Arrizola L; Barricarte A; Navarro C; Rodriguez L; Bingham S; Linseisen J; Kaaks R; Overvad K; Tjønneland A; Peeters PH; Numans ME; Clavel-Chapelon F; Boutron-Ruault MC; Morois S; Trichopoulou A; Lund E; Plebani M; Riboli E; González CA
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):28-38. PubMed ID: 20056620
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study.
Hazra A; Wu K; Kraft P; Fuchs CS; Giovannucci EL; Hunter DJ
Carcinogenesis; 2007 Jul; 28(7):1510-9. PubMed ID: 17389618
[TBL] [Abstract][Full Text] [Related]
13. The relationships between plasma and red cell vitamin B2 and B6 concentrations and the systemic and local inflammatory responses in patients with colorectal cancer.
Leung EY; Roxburgh CS; Talwar D; O'Reilly DS; McKee RF; Horgan PG; McMillan DC
Nutr Cancer; 2012; 64(4):515-20. PubMed ID: 22439733
[TBL] [Abstract][Full Text] [Related]
14. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.
Peters U; Hayes RB; Chatterjee N; Shao W; Schoen RE; Pinsky P; Hollis BW; McGlynn KA;
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):546-52. PubMed ID: 15066918
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene.
Kune G; Watson L
Nutr Cancer; 2006; 56(1):11-21. PubMed ID: 17176213
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps.
Ulrich CM; Kampman E; Bigler J; Schwartz SM; Chen C; Bostick R; Fosdick L; Beresford SA; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):427-33. PubMed ID: 10794488
[TBL] [Abstract][Full Text] [Related]
17. Plasma tocopherol and prevalence of colorectal adenomas in a multiethnic population.
Ingles SA; Bird CL; Shikany JM; Frankl HD; Lee ER; Haile RW
Cancer Res; 1998 Feb; 58(4):661-6. PubMed ID: 9485018
[TBL] [Abstract][Full Text] [Related]
18. Folate intake, MTHFR C677T polymorphism, alcohol consumption, and risk for sporadic colorectal adenoma (United States).
Boyapati SM; Bostick RM; McGlynn KA; Fina MF; Roufail WM; Geisinger KR; Hebert JR; Coker A; Wargovich M
Cancer Causes Control; 2004 Jun; 15(5):493-501. PubMed ID: 15286469
[TBL] [Abstract][Full Text] [Related]
19. Plasma B vitamins and LINE-1 DNA methylation in leukocytes of patients with a history of colorectal adenomas.
Jung AY; Botma A; Lute C; Blom HJ; Ueland PM; Kvalheim G; Midttun Ø; Nagengast F; Steegenga W; Kampman E
Mol Nutr Food Res; 2013 Apr; 57(4):698-708. PubMed ID: 23132835
[TBL] [Abstract][Full Text] [Related]
20. Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-γ-mediated immune activation in the community-based Hordaland Health Study.
Theofylaktopoulou D; Ulvik A; Midttun Ø; Ueland PM; Vollset SE; Nygård O; Hustad S; Tell GS; Eussen SJ
Br J Nutr; 2014 Oct; 112(7):1065-72. PubMed ID: 25105221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
